| 摘要 |
This invention is related to a compound of formula (1) and the pharmaceutically acceptable salts thereof, wherein X, R1, R2, Y1 and Y2 are as described herein. These compounds inhibit the interaction of MDM2 protein with a p-53-like peptide and therefore exhibit antiproliferative activity.
|
